Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-12

Clinical Trial Update: Subdermal Implant-bioabsorbable Gestrinone Pellet for Endometriosis Pelvic Pain Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a bioabsorbable subdermal Gestrinone pellet for endometriosis-related pelvic pain has completed; the update does not report trial outco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gestrinone pellet (Gestrinone)

Snippet

Sponsor: Science Valley Research Institute | Conditions: Deep Endometriosis, Pelvic Pain | Phase 2 | Status: COMPLETED